Fabio Boniolo

Is this you? Claim the profile to see who's watching you ›

Request an intro

SVTR SignalCo-founder & CSO·Polyphron ★ RatedLinkedIn

Position in SVTR

Snapshot 2026-11-05

People SignalsTop 50%↓31

🔒 Sign in for the exact rank and neighbours

Elite School

Experience

PolyphronCo-founder & CSO
2025–
Dana-Farber Cancer Institute / Harvard Medical School / Broad InstitutePostdoctoral Researcher

Education

Technical University of MunichPhD

Full bio

PhD from the Technical University of Munich, with postdoctoral research at the Dana-Farber Cancer Institute/Harvard Medical School/Broad Institute in tissue engineering, biofabrication and translational oncology;…

Latest moves

1 sourced move in the last 90 days · Unlock with SVTR Intelligence

Funding of companies this person currently works at, from the SVTR AI Venture Database.

Timeline

2022PaperEpigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype ↗JCI Insight
2022PaperSelective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment ↗Nature Cancer
2021PaperArtificial intelligence in early drug discovery enabling precision medicine ↗Expert Opinion on Drug Discovery

SVTR coverage mentioning this person, plus selected papers (affiliation verified per paper).

Relationship graph

Colleague / same employer· 2

Matthew Osman Vinh Q. Tran

Schoolmate· 4

Khalil Kaddoura Roman Hölzl Artur Koop Philipp Wiegand

Org / employer· 2

PolyphronDana-Farber Cancer Institute / Harvard Medical School / Broad Institute

School· 1

Technical University of Munich

⬇

Co-founderColleague / same employerSchoolmateOrg / employerSchoolBigger circle = more prominent (media coverage) · ⛶ fullscreen · scroll / pinch to zoom · hover to highlight · drag nodes · click a node to open its profile